Experimental Study on ATA Prescription in Treating Monkey with Chronic Infection of Simian Immunodeficiency Virus
Experimental Study on ATA Prescription in Treating Monkey with Chronic Infection of Simian Immunodeficiency Virus
复制标题
DOI:
--
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Fu Linchun
中科院分区:
文献类型:
--
作者:
Fu Linchun
[Objective] To investigate the effect of ATA, a herbal medicine compound, for the treatment of the chronic infection of simian immunodeficiency virus ( SIV) in monkeys. [ Methods ] Eight Rhesus monkeys were infected with SIVmac251 to establish monkey models with chronic infection of SIV. After 18 months, the monkeys were randomized into model group and ATA group, administered with saline and ATA 2 g·kg-1·d-1 for 56 days respectively. The changes of signs were observed, plasma levels of T-lymphocyte subsets CD4+ and CD8+ were detected by flow cytometry and the lymph node biopsy were observed under light microscope before and after treatment. [Results] After treatment, the body weight increased and the incidence of infective diarrhea decreased in ATA group, the difference being insignificant. ATA had no obvious effect on white blood cells counting and the replication number of plasma SIV, but increased the plasma levels of T-lymphocyte subsets CD4+ and CD8+(P0.05 compared with the model group). Before treatment, the degeneration and exhaustion of lymph node existed in the two groups; however, there appeared the reconstruction of lymph node such as lymph follicle proliferating, germinal center expanding and immune cells growing in ATA group after treatment. [Conclusion] ATA has a certain effect on the recovery and reconstruction of immune function in monkeys with chronic infection of SIV but has no obvious anti-virus effect.